Atacand Hct is a drug owned by Ani Pharmaceuticals Inc. It is protected by 5 US drug patents filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Feb 24, 2015. Details of Atacand Hct's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5721263 | Pharmaceutical composition for angiotensin II-mediated diseases |
Feb, 2015
(9 years ago) |
Expired
|
| US5958961 | Pharmaceutical composition for angiotensin II-mediated diseases |
Jun, 2014
(10 years ago) |
Expired
|
|
US5534534 (Pediatric) | Pharmaceutical compositions for oral use and method of preparing them |
Jan, 2014
(10 years ago) |
Expired
|
| US5534534 | Pharmaceutical compositions for oral use and method of preparing them |
Jul, 2013
(11 years ago) |
Expired
|
|
US5196444 (Pediatric) | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec, 2012
(12 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Atacand Hct is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Atacand Hct's family patents as well as insights into ongoing legal events on those patents.
Atacand Hct's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Atacand Hct's generic launch date based on the expiry of its last outstanding patent is estimated to be Feb 24, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Atacand Hct Generic API suppliers:
Candesartan Cilexetil; Hydrochlorothiazide is the generic name for the brand Atacand Hct. 6 different companies have already filed for the generic of Atacand Hct, with Apotex Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Atacand Hct's generic
How can I launch a generic of Atacand Hct before its drug patent expiration? :
You can seek FDA approval to launch a generic drug before the expiration of Atacand Hct's patents related by providing a 'paragraph IV certification' in your application, which states that the patent submitted by the Atacand Hct's sponsor is invalid, unenforceable, or will not be infringed by your generic product.
Given below are the details of the already filed Para IV certificates on Atacand Hct -
| Strength | Submission Date | ANDA(s) Filed | First applicant approval | Last patent expiry | 180 day status |
|---|---|---|---|---|---|
| 16 mg/12.5 mg and 32 mg/12.5 mg | 25 Jun, 2008 | 1 | 04 Dec, 2012 | 24 Feb, 2015 | Extinguished |
| 32 mg/25 mg | 06 Mar, 2009 | 1 | 04 Dec, 2012 | 24 Feb, 2015 | Eligible |
Alternative Brands for Atacand Hct
Atacand Hct which is used for treating high blood pressure., has several other brand drugs in the same treatment category . Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | Treatment Area | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbott |
| |||||||||||||||
| Abbvie |
| |||||||||||||||
| Adhera |
| |||||||||||||||
| Allergan |
| |||||||||||||||
| Azurity |
| |||||||||||||||
| Boehringer Ingelheim |
| |||||||||||||||
| Cosette |
| |||||||||||||||
| Noden Pharma |
| |||||||||||||||
| Novartis |
| |||||||||||||||
| Upjohn |
| |||||||||||||||
| Waylis Therap |
| |||||||||||||||
About Atacand Hct
Atacand Hct is a drug owned by Ani Pharmaceuticals Inc. It is used for treating high blood pressure. Atacand Hct uses Candesartan Cilexetil; Hydrochlorothiazide as an active ingredient. Atacand Hct was launched by Ani Pharms in 2000.
Approval Date:
Atacand Hct was approved by FDA for market use on 05 September, 2000.
Active Ingredient:
Atacand Hct uses Candesartan Cilexetil; Hydrochlorothiazide as the active ingredient. Check out other Drugs and Companies using Candesartan Cilexetil; Hydrochlorothiazide ingredient
Treatment:
Atacand Hct is used for treating high blood pressure.
Dosage:
Atacand Hct is available in tablet form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 32MG;25MG | TABLET | Prescription | ORAL |
| 16MG;12.5MG | TABLET | Prescription | ORAL |
| 32MG;12.5MG | TABLET | Prescription | ORAL |